Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Neyssa Marina(Coherus BioSciences (United States)), Lisa A. Teot(Boston Children's Hospital), Pancras C.W. Hogendoorn(Vrije Universiteit Brussel), Trude Butterfaß‐Bahloul(University Hospital Münster), Heike E. Daldrup‐Link(Lucile Packard Children's Hospital), Henk van den Berg(Emma Kinderziekenhuis), Paul A. Meyers(Memorial Sloan Kettering Cancer Center), Holcombe E. Grier(Harvard University), Jendrik Hardes(Ruhrlandklinik), Patrick J. Leavey(Children's Medical Center), Michaela Nathrath(Klinikum Kassel), Gordana Jovic(MRC Clinical Trials Unit at UCL), Gabriele Calaminus(University Hospital Bonn), Cindy L. Schwartz(Brown University), Hans Gelderblom(Leiden University Medical Center), K. Helmke(Universität Hamburg), Stefan Bielack(Olgahospital), Michael S. Isakoff(Center for Cancer and Blood Disorders), Richard Görlick(The University of Texas MD Anderson Cancer Center), Mikael Eriksson(Herlev Hospital), Hubert Mottl(University Hospital in Motol), Peter Reichardt(Helios Hospital Berlin-Buch), Allen M. Goorin(Dana-Farber Cancer Institute), R. Lor Randall(University of California Davis Medical Center), Bénédicte Brichard(Cliniques Universitaires Saint-Luc), Katherine A. Janeway(Harvard University), Robert E. Goldsby(University of California San Francisco Medical Center), Sandra J. Strauss(University College Hospital), Bernadette Brennan(Royal Manchester Children's Hospital), Mark L. Bernstein(University of Louisville), Ken Brown(University of British Columbia), Leo Mascarenhas(University of Southern California), Zsuzsanna Pápai(National Institute of Oncology), Ching C. Lau(University of Hong Kong), Michaël C.G. Stevens(Royal Hospital for Children), Sigbjørn Smeland(Oslo University Hospital), Mark C. Gebhardt(Boston Children's Hospital), Douglas S. Hawkins(Seattle Children's Hospital), Kirsten Sundby Hall(Oslo University Hospital), Mark Krailo(Arcadia), Akmal Safwat(Aarhus University Hospital), Stephen L. Lessnick(Nationwide Children's Hospital), Thomas Kühne(University Children’s Hospital Basel), Marleen Renard, Carola Arndt(Mayo Clinic), Heribert Jürgens(University Hospital Münster), Jane Hook(University of Leeds), Leo Kager(University of Vienna), Juliet Hale(Newcastle upon Tyne Hospital), Joachim Gerß
Cited by 537
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
|Nature|2007|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k